Antihypertensive Drugs Market Projected to Expand at a CAGR of 3.0% from 2022 to 2030, Data by Contrive Datum Insights

Farmington, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The Antihypertensive Drugs Market is estimated to reach a valuation of USD 30.2 Billion by 2022, growing at 3.0% CAGR during the assessment period 2022-2030. High blood pressure is treated with antihypertensive drugs. There are different kinds of drugs that help lower high blood pressure on the market. These are good for lowering blood pressure. Some take away extra water and salt from the body, while others help blood vessels relax and open up or slow the heart rate. One drug works better for a person than another, and it also has fewer side effects.

Request Sample Copy of Report “Antihypertensive Drugs Market - Global Industry Analysis, Size, Share, Growth Opportunities, Future Trends, Covid-19 Impact, SWOT Analysis, Competition, and Forecasts 2022 to 2030”, published by Contrive Datum Insights.

Some people need more than one medicine to lower their blood pressure. Hypertension is a long-term medical condition in which the blood pressure in the arteries stays high over time. Antihypertensive drugs are used to treat people with hypertension, which is another name for high blood pressure. High blood pressure is a serious condition that can lead to heart attack, heart failure, and dementia, among other serious problems. So, hypertension needs to be found and treated quickly. High blood pressure can be treated with diuretics, ACE inhibitors, and vasodilators, among other medicines.

Antihypertensive Drugs Market Recent Developments:

• April 2021 Radnor Biopharma develops a hormone-targeted therapy for high blood pressure
• In 2018, CFDA provided a new clinical approval process, allowing companies to carry out clinical trials in the absence of any opinion from the Center for Drug Evaluation within the prescribed time limit
• In July 2018, Daiichi Sankyo Co., Ltd.’s antihypertensive drug Civeka

Antihypertensive Drugs Market Segmentation Analysis:

The market for antihypertensive drugs describes a few key therapeutic classes, such as beta-adrenergic blockers, calcium channel blockers, angiotensin receptor blockers, angiotensin-converting enzyme (ACE) inhibitors, renin inhibitors, diuretics, vasodilators, and other. Recent studies have found that beta blockers and diuretics, which are used to treat high blood pressure, are much cheaper than other therapeutic classes. As a result, they are in high demand on the market for antihypertensive drugs.
There are both primary and secondary antihypertensive drugs on the market. This depends on the type of drug. The secondary hypertension segment is in the lead due to early diagnosis, faster detection, rising cases of thyroid problems, long-term alcohol use, kidney problems, heart problems, adrenal gland tumours, and more.
Retail pharmacies, hospital pharmacies, e-commerce websites, online drug stores, and others. Due to the high number of people who use the internet and the popularity of smartphones and tablets, e-commerce websites and online drug stores are likely to grow at the fastest rate during the period under review.

Regional Outlook:

In 2018, North America was the biggest market for antihypertensive drugs because they are easy to get. This is likely to continue in the near future because antihypertensive drugs are easy to get. The market in this region is also growing because the number of people over 65 is growing and the number of people with high blood pressure is going up. But Asia Pacific is expected to grow the most over the next few years because more people are learning about the benefits of antihypertensive drugs. In developing economies like India, China, and Malaysia, the growth of the market is also driven by the growth of the life sciences industry.

Buy this Premium Research Report@
https://www.contrivedatuminsights.com/buy/64880/?Mode=TM

Scope of Report:

Antihypertensive Drugs Market dynamics:
Drivers
The alarming rise of hypertension around the world is one of the most important things driving growth in the antihypertensive drugs market. The growing number of cases is also making more people aware of the problems caused by high blood pressure, which also helps the market grow. The growing number of older people around the world and the high number of people who don't move much also contribute to big growth. Antihypertensive drugs are in more demand on the market because of the growing need to find and treat hypertension as soon as possible.

Opportunities

Compared to single therapies, combination therapies have been used a lot more in recent years. Monotherapy uses just one drug, while combination therapy uses more than one drug to treat high blood pressure. In the second method, two drugs with different ways of working are put together. This gives a much stronger effect than a single drug. Combination therapy helps reduce strokes and heart attacks by 54% and heart problems by 40%. So, combination therapy protects the organ better with lower doses than monotherapy, and its wide use around the world is turning out to be a good business opportunity for the top companies in the world industry.

Restraints

Lower awareness levels with regard to antihypertensive drugs amongst the mass in developing countries can be a huge restraint in the worldwide market. A lot of people in developing countries don't get regular health checks and don't know much about hypertension and its signs. This makes it hard for businesses to make money in these areas.

Antihypertensive Drugs Market Key Segments Covered:

Top Market Players:
Alvogen, AstraZeneca plc, Bayer AG, Bellerophon Therapeutics, Inc., Boehringer Ingelheim GmbH, Boryung Pharmaceutical Co., Ltd., Bristol-Myers Squibb and Company, Daiichi Sankyo Company, Gilead Sciences, Inc., Eli Lilly and Company, HanAll Biopharma Co., Ltd., Hanmi Pharmaceutical Co., Ltd., Johnson & Johnson (Actelion Pharmaceuticals Ltd.), JW Pharmaceutical Corporation (Choongwae Pharma), Kyowa Kirin Co., Ltd., Lung Biotechnology PBC, Merck & Co., Inc., Nippon Shinyaku Co. Ltd., Novartis AG, Pfizer, Inc., Purple Biotech (Kitov Pharmaceuticals), Sanofi SA, Servier Laboratories, Stendhal Pharma, Reata Pharmaceuticals, Inc., Takeda Pharmaceutical Co., Ltd., United Therapeutics Corporation, Yuhan Co, Ltd., and Others.

Antihypertensive Drugs Market by Types:

• Primary Hypertension
• Secondary Hypertension

Therapy Type

• Diuretics
• Angiotensin Converting Enzyme Inhibitors
• Angiotensin Receptor Blockers
• Beta-blockers
• Vasodilators
• Calcium Channel Blockers
• Renin Inhibitors
• Alpha-blockers
• Others

Medication Type

• Monotherapy
• Combination Therapy
• Fixed Dose Combinations

Antihypertensive Drugs Market by Applications:

• Retail Pharmacy
• Hospital Pharmacy
• E-commerce Websites & Online Drug Stores

Regions and Countries Covered

• North America: (US, Canada, Mexico, Rest of North America)
• Europe: (Germany, France, Italy, Spain, UK, Nordic Countries, Benelux Union, Rest of Europe)
• Asia-Pacific: (Japan, China, India, Australia, South Korea, Southeast Asia, Rest of Asia-Pacific)
• The Middle East & Africa: (Saudi Arabia, UAE, Egypt, South Africa, Rest of the Middle East & Africa)
• Latin America: (Brazil, Argentina, Rest of Latin America)
• Rest Of the World

Check out more related studies published by Contrive Datum Insights:

• Hospital Injectable Drugs Market - The Hospital Injectable Drugs Market is projected to grow from USD 38.7 billion in 2021, at a CAGR of around 4.8% during the forecast period. North America accounted for the largest market share in 2020 and is projected to grow at a solid CAGR during the review period. This can be attributed to the high adoption rate of advanced diagnostic equipment combined with the presence of key market players such as Kemper Medical, Inc. (US) and Chemyx, Inc. (US).
• HIV Drugs Market – The global HIV drugs market size was valued at USD 30.89 billion in 2019, and is expected to reach USD 36.495 billion by 2027, and is growing at a CAGR of 3.8% during the forecast period from 2020 to 2027. On the basis of region, the global market can be segmented into North America, Europe, Asia Pacific, and Rest of the World. North America is expected to dominate the forecast period, with a market size of USD 20.27 billion by 2020. The dominance of the region is attributed to the rising prevalence of HIV infection among the U.S. population. According to a 2021 study by the Centers for Disease Control (CDC), approximately 1.2 million people were living with HIV at the end of 2018.
• Poultry Drugs Market - The global Poultry Drugs Market size is projected to grow at a CAGR of 10% during the forecast period from 2022 - 2030. The poultry drugs market in North America is expected to grow over the forecast period of 2021-2030. Growth in major poultry-producing countries such as Mexico and Canada, and rising production rates in various regions owing to rising demand for meat products are factors that propel the growth of this industry.
• Aerosol Therapy Market - The Global Aerosol Therapy Market Is Expected To Grow At A CAGR Of 5.5% From 2022 To 2030. Aerosols are suspensions of liquid or solid particles in a carrier gas and are used to treat respiratory-related diseases. North America is expected to dominate the market in this proportion. The Asia Pacific (mostly China and India) market is expected to grow at a relatively rapid pace during the forecast period.

Customization of the Report: The report can be customized as per client needs or requirements.For any queries, you can contact us at anna@contrivedatuminsights.com or +1 215-297-4078. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.

About Us:
Contrive Datum Insights (CDI) is a global delivery partner of market intelligence and consulting services to officials at various sectors such as investment, information technology, telecommunication, consumer technology, and manufacturing markets. CDI assists investment communities, business executives, and IT professionals to undertake statistics-based accurate decisions on technology purchases and advance strong growth tactics to sustain market competitiveness. Comprising of a team size of more than 100 analysts and cumulative market experience of more than 200 years, Contrive Datum Insights guarantees the delivery of industry knowledge combined with global and country-level expertise.

Social: Facebook / LinkedIn / Twitter

Contact Us:
Anna B. | Head Of Sales
Contrive Datum Insights
Phone: +91 9834816757 | +1 2152974078
Email: anna@contrivedatuminsights.com

Website:
https://www.contrivedatuminsights.com
Contrive Datum Insights Press Releases
Latest Contrive Datum Insights Latest Reports